Synopsis:- Mutual funds raised stakes across multiple stocks in Q3FY26, with holdings increasing by 0.46–1.16 percentage points. Institutional ownership strengthened despite mixed price moves, while scheme participation expanded in select names, reflecting growing confidence driven by sectoral diversification, stable earnings visibility, and long-term investment optimism.
Mutual fund investments saw notable growth in Q3FY26, reflecting renewed investor confidence and strong market participation. Both equity and diversified schemes attracted increased inflows, driven by robust corporate earnings, festive-season optimism, and rising interest in long-term wealth creation. This uptick underscores investors’ appetite for structured investment solutions amid evolving market opportunities. Here are the listed stocks
Aditya Birla Capital is the financial services arm of the Aditya Birla Group, offering a diversified portfolio across lending, insurance, asset management, wealth management, and capital markets. With a strong retail focus and integrated financial solutions, the company benefits from cross-selling opportunities and rising demand for credit and protection products in India. With a market capitalization of Rs 93,253 crore, the shares closed at Rs 356 per share, decreased by 1.33 percent as compared to the previous closing price.
Mutual fund ownership in the stock rose meaningfully during the December 2025 quarter, with holdings increasing by 1.16 percentage points, from 6.52% to 7.68%. The number of mutual fund schemes invested also climbed from 65 to 67, signalling improving institutional confidence and rising interest from professional investors in the company’s long-term prospects.
AWL Agri Business is a leading agri-processing and food FMCG company with strong presence across edible oils, packaged foods, and agricultural commodities. Backed by a wide sourcing network and robust distribution, the company plays a key role in India’s food value chain, benefiting from consumption growth and branded food penetration. With a market capitalization of Rs 29,593 crore, the shares closed at Rs 228 per share, decreased by 0.52 percent as compared to the previous closing price.
Mutual fund holdings in the stock rose by 0.64 percentage points during the December 2025 quarter, increasing from 8.37% to 9.01%. While ownership levels improved, the number of mutual fund schemes remained unchanged at 22, indicating higher allocation by existing funds rather than fresh scheme additions.
JB Chemicals and Pharmaceuticals is a well-established pharma company with leadership in domestic branded formulations and a growing international footprint. Known for strong brands in chronic therapies, the company focuses on steady cash generation, margin discipline, and expanding exports, supported by manufacturing capabilities and a diversified product portfolio. With a market capitalization of Rs 29,914 crore, the shares closed at Rs 1,911 per share, decreased by 1.14 percent as compared to the previous closing price.
Mutual fund ownership in the stock improved during the December 2025 quarter, with holdings rising by 0.46 percentage points from 19.15% to 19.61%. The number of mutual fund schemes invested remained unchanged at 33, indicating higher exposure by existing funds rather than new scheme participation.
Apollo Hospitals Enterprise is India’s largest integrated healthcare provider, operating hospitals, pharmacies, diagnostics, and digital health platforms. With a strong brand, pan-India presence, and focus on high-end clinical services, the company benefits from rising healthcare demand, medical tourism, and increasing insurance penetration. With a market capitalization of Rs 1,05,633 crore, the shares closed at Rs 7,348 per share, decreased by 1.35 percent as compared to the previous closing price.
Mutual fund participation strengthened during the December 2025 quarter, with holdings rising by 0.27 percentage points from 16.48% to 16.75%. The number of mutual fund schemes invested also increased from 349 to 358, reflecting broader institutional interest and growing confidence among fund managers in the stock’s outlook.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
